Skip to main content
VIVS logo

VivoSim Labs, Inc.

VIVSNASDAQHealthcareBiotechnology

$0.17Today:- (-)1Y −93.45%

As of Oct 15, 2026 close

Market cap
$546.22K
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.16$3.40
Volume (live)
-
Avg. volume (3M)
925.49K

VivoSim Labs (VIVS) Cash Flow Statement

In fiscal 2026 (fiscal year ended Mar 31, 2026), VivoSim Labs used $10.83M of cash in operating activities. Free cash flow was −$10.83M.

VivoSim Labs Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for VivoSim Labs, Inc. (VIVS) - Annual data in millions USD
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2018FY 2017
Period endingMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2019Mar 2017
Operating Activities
Net Income-13.84-2.49-14.67-11.45-11.45-18.71-26.64-38.45
Depreciation & Amortization0.220.270.280.140.141.140.981.15
Stock Based Compensation0.300.531.512.262.264.115.197.39
Change in Working Capital-0.681.04-2.020.600.60-1.000.020.67
Change in Accounts Receivable0.000.000.120.00-0.150.450.47-0.39
Change in Inventory0.00-0.50-0.300.000.000.280.35-0.22
Change in Accounts Payable-0.621.020.300.130.130.090.160.38
Change in Other Working Capital0.18-0.20-0.020.460.41-1.81-0.960.89
Other Operating Activities3.19-8.810.250.00-0.13-0.420.060.05
Net Cash from Operating Activities-10.83-9.46-14.65-8.45-8.45-14.88-20.38-29.19
Investing Activities
Capital Expenditures0.00-0.01-0.04-0.41-0.410.00-0.08-1.35
Purchases of Investments0.00-2.96-10.860.00-10.950.000.000.00
Sales/Maturities of Investments0.093.0011.720.0010.000.000.000.00
Other Investing Activities0.009.000.000.000.010.750.00-0.04
Net Cash from Investing Activities0.099.030.82-0.41-0.410.75-0.08-1.39
Financing Activities
Debt Repayment-0.360.000.000.000.000.000.000.00
Common Stock Issued4.818.851.440.250.255.0013.3330.67
Common Stock Repurchased0.000.000.000.00-0.050.000.000.00
Other Financing Activities-0.360.000.00-0.050.04-0.06-0.170.58
Net Cash from Financing Activities4.458.851.440.210.214.9413.1531.25
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.000.00-0.01
Net Change in Cash-6.298.41-12.40-8.66-8.66-9.20-7.300.66
Cash at Beginning of Period11.463.0428.8237.4827.3636.5643.8562.09
Cash at End of Period5.1711.4615.4428.8237.4827.3636.5662.75
Free Cash Flow-10.83-9.47-14.70-8.86-8.86-14.88-20.45-30.54
Supplemental Disclosures
Interest Paid-0.01------
Income Taxes Paid-0.000.000.000.000.00--

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About VivoSim Labs Cash Flow

What is VivoSim Labs's free cash flow?

VivoSim Labs had negative free cash flow of $10.83M in fiscal 2026 (fiscal year ended Mar 31, 2026).

Does VivoSim Labs pay dividends or buy back shares?

VivoSim Labs's cash flow statement for fiscal 2026 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition